The company is particularly unfriendly to newcomers, more overtime, serious atmosphere at work, do not speak, but the welfare benefits are not bad, the future may have the opportunity to go public, just enter the community of two or three years of white, do not come, if you are a famous company parachuted over, there are other companies do not choose this one.
Denovo Medical is a professional innovative life science and technology industry investment, incubation and operation enterprise, headquartered in Hangzhou, in China, the United States, Israel, with overseas R & D centers (the United States 4, Israel 1).
DenuMed aims to fill the gaps in the domestic market and introduce the world's leading technologies, discovering, investing in and integrating medical projects with disruptive and innovative technologies in the industry globally, and committing itself to seeking effective treatment solutions for major diseases that pose serious threats to human health, but for which there is currently a lack of effective means.
Denault Medical has a strong team of international medical consultants (composed of renowned clinicians and industry experts at home and abroad), and with rich industry experience, adopts the dual-track model of independent innovation and introduction, digestion, absorption and re-innovation to realize the localization and industrialization of global innovative medical technologies in China.
Denault Medical owns a professional venture capital fund, which utilizes capital, resources, and industry experience to incubate early stage innovative life science and technology projects in China and accelerate their growth and industrialization. At the same time, the venture capital fund introduces foreign top medical technology projects and localizes the technology through digestion, absorption and re-innovation. At this stage, we are focusing on innovative diagnostic and treatment technologies for cardiovascular diseases, tumors and diabetes.
Denault Medical adopts a corporate management and operation model, and each project is located in the form of a project company. In addition to providing GMP-compliant plants, equipment and facilities, and property services, Deloitte Medical also provides a series of specialized value-added services, including: technical consulting, regulatory consulting, market information services, patent services, animal experiment platforms, clinical trials, medical device product registration, industrialization platforms, and market promotion.
Denault Medical will build a life science and technology industry innovation and incubation gas pedal with resources and services***, form an open, integrated and sustainable life science and technology industry innovation ecosystem, create a number of industrial and academic highlands in the field of life science and technology in China, drive the synergistic development of the industry, improve the academic status and international influence of domestic medical research institutions in the relevant fields, and contribute to the development of China's life science and technology industry. technology industry in China.
DeNuo Medical has built an innovation platform with the ability to incubate the latest international cutting-edge medical technology projects, and currently owns a number of projects, such as lung cancer early diagnosis and treatment devices (Broncus), peripheral vascular interventional devices (Viktor Medical), structural heart disease interventional devices (Nomo Medical), and cardiac valve repair devices (Dejin Medical).
DenuMed Hangzhou Incubator has a 12,000-square-meter incubation facility in Binjiang District, Hangzhou, which is used for the production and operation of incubation projects, and employs nearly 1,000 people including the incubation projects, of which 15% are overseas employees.